Sequencing Considerations in mCRPC

Stanford Medicine
J

Stanford Medicine Historical Landscape of Testing: Blood-Based Diagnostic Biomarkers & Screening

By Stanford Medicine FEATURING John Leppert
By Stanford Medicine FEATURING John Leppert
37 views
July 9, 2022
Comments 0
Login to view comments. Click here to Login
51

Lecture Summary - CARD Trial: Safety and Efficacy of Cabazitaxel in …

Dana-Farber Cancer Institute

A. Choudhury

18 views
09:06

CARD Trial: Safety and Efficacy of Cabazitaxel in mCRPC & Age Subgro…

Dana-Farber Cancer Institute

A. Choudhury

167 views
08:33

Challenging Genitourinary Tumors: What’s New in Prostate Cancer

Penn Medicine Abramson Cancer Center

V. Narayan

77 views
22:50

Genetics/Genomics in Prostate Cancer

Stanford Medicine

M. Cooperberg

91 views
38:10

ASCO 2022 Updates on Molecular Based Imaging for Prostate Cancer: Re…

Nebraska Oncology Society

T. Hope

242 views
21:43

ASCO 2022 on the Latest Developments in mHSPC and mCRPC

ecancer

H. Payne, K. Chi, K. Miller, L. Krabbe

238 views
44:50

New Therapeutic Discoveries and Mechanisms for CRPC

Masonic Cancer Center, University of Minnesota

K. Kelly

91 views
14:33

Prostate Cancer Imaging Updates: What, Why, and When

Martin Allen-Auerbach

898 views
06:00

Cabazitaxel Activity in Men With mCRPC With & Without DNA Damage Rep…

Elena Castro

243 views
10:02

The Role of Biomarkers in mCRPC

Eleni Efstathiou

177 views
13:49

Finding the Optimal Sequence for mCRPC

Benjamin L. Maughan

349 views
07:31

Second Line Therapy Options in mCRPC

Karam Al-Issa

159 views
06:12

Patient Preference Between Cabazitaxel and Docetaxel for 1L Chemothe…

Giulia Baciarello

168 views